New England Focus on LTBI

Date: December 1 and December 8
Location: Online

COURSE DESCRIPTION & OVERALL GOAL
The purpose of this training is to increase providers’ awareness and knowledge on the current recommendations for testing and treatment for TB infection.

Tuesday, December 1, 2020
10:00 - 11:00 AM - Diagnosis of LTBI 

Tuesday, December 8, 2020
10:00 - 11:00 AM - Shorter Regimens for Treatment of LTBI

WHO SHOULD ATTEND
This conference is primarily designed for clinicians who are involved in the diagnosis, treatment and management of persons with latent TB infection and disease. The content will be applicable for physicians, physician assistants, nurse practitioners, fellows, and residents. Public health nurses and others working in TB control are welcome to attend.

WHY COURSE IS NEEDED
As the incidence of TB continues to decline, maintaining clinical expertise is particularly challenging especially as the cases are more complex to diagnosis and manage. Ongoing training and education are important for clinicians so they can develop and enhance skills in the diagnosis of TB, follow recommended treatment guidelines, and interact effectively with public health agencies.

OBJECTIVES
Upon completion of this conference, participants should be better able to:

• Describe the rationale for prioritizing identification and treatment for LTBI as a necessary strategy for the elimination of TB in the US
• Select appropriate tests for LTBI screening, diagnosis of TB disease and monitoring patients during treatment.
• Implement current recommendations to increase treatment completion among patients with TB infection.

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend live webinar sessions and complete an evaluation form. A follow-up evaluation will be sent within 2 months of the course.

CONTINUING EDUCATION INFORMATION
In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the New England TB Consortium. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 1.0 contact hour (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

REGISTRATION INFORMATION & FEE
There is no fee for this conference. Participants need to register separately for the two webinars.

December 1 - Diagnosis of LTBI:

Please click here to register

December 8 - Shorter Regimens for Treatment of LTBI:

Please click here to register

FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Shwata Suresh Kumar at ss2980@rutgers.edu.